


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
BDX
Becton, Dickinson and
$198.40
Strengths

Earnings are forecast to grow

Expands stock buyback program
BDX Price Performance
$192.12 (+3.27%)
$186.17 (+6.57%)
$175.33 (+13.16%)
$226.95 (-12.58%)
BDX has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk

BDX overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Reported a weak earnings

Earnings increase YoY
Rating
Rating
Momentum
Momentum

Has been gaining momentum
Activity
Activity

Expands stock buyback program
Future
Future

Earnings are forecast to grow
![]()
BDX Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
BDX Street Sentiment is bullish and have positive views on the near-term outlook
Average key support and resistance price levels
Login to displayBSX
92.70
+0.18%
TFX
130.50
-0.58%
RMD
251.50
+2.02%
IRTC
172.37
-0.73%
What is BDX current stock price?
What are BDX stock strengths?
What is BDX Risk Level?
What is BDX market cap and volume?
What is BDX current Stock IQ?
Should I buy BDX stock right now?
Is BDX a Strong Buy right now?
What does a 'Strong Buy' rating mean for BDX?
What does a 'Strong Sell' rating mean for BDX?
What factors influence BDX's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
BDX
Becton, Dickinson and
Current Price
$198.40
Stock Insights
Strengths

Earnings are forecast to grow

Expands stock buyback program
Linked to BDX
BSX
92.70
+0.18%
TFX
130.50
-0.58%
RMD
251.50
+2.02%
IRTC
172.37
-0.73%

BDX Price Performance
$192.12 (+3.27%)
$186.17 (+6.57%)
$175.33 (+13.16%)
$226.95 (-12.58%)
BDX Analysts Opinion
BDX Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Reported a weak earnings

Earnings increase YoY
Rating
Rating
Momentum
Momentum

Has been gaining momentum
Activity
Activity

Expands stock buyback program
Future
Future

Earnings are forecast to grow
![]()
BDX Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
BDX Street Sentiment is bullish and have positive views on the near-term outlook
BDX has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk

Average key support and resistance price levels
BDX Stock IQ
BDX Latest Analysis
BDX Makes Notable Cross Below Critical Moving Average. In trading on Monday shares of Becton Dickinson &. Co (Symbol: BDX) crossed below their 200 day moving average of $191.25 changing hands as low as $189.50 per share. Becton Dickinson &. Co shares are currently trading down about 1.7% on the day. The chart below shows
Mon Dec 8, 2025
Ex-Dividend Reminder: Becton Dickinson Nicolet Bankshares and UnitedHealth Group . Looking at the universe of stocks we cover at Dividend Channel on 12/8/25 Becton Dickinson &. Co (Symbol: BDX) Nicolet Bankshares Inc (Symbol: NIC) and UnitedHealth Group Inc (Symbol: UNH) will all trade ex-dividend for their respective upcoming dividends. Becton Dickin
Thu Dec 4, 2025
Jim Cramer on Waters Corporation: I Think It Should Be Loved on Wall Street. Waters Corporation (NYSE:WAT) is one of the stocks Jim Cramer recently discussed. Cramer discussed the companys upcoming merger with Becton Dickinsons biosciences and diagnostics business. He remarked: Finally please dont forget about one that was always my personal favorite never owned it for the trust Waters Corporation one of the quieter companies in this space [….]
Thu Dec 4, 2025
Morgan Stanley Maintains Becton Dickinson and (BDX) Overweight Recommendation. Fintel reports that on December 2 2025 Morgan Stanley maintained coverage of Becton Dickinson and (NYSE:BDX) with a Overweight recommendation. Analyst Price Forecast Suggests 9.24% Upside
Wed Dec 3, 2025
Heres Why Becton Dickinson (BDX) is a Strong Value Stock. Whether youre a value growth or momentum investor finding strong stocks becomes easier with the Zacks Style Scores a top feature of the Zacks Premium research service.
Tue Nov 25, 2025
BD Launches Surgiphor Surgical Wound Irrigation System In Europe . (RTTNews) - Becton Dickinson and Company (BDX) a medical technology company said Monday that it has launched the BD Surgiphor Surgical Wound Irrigation System in Europe. The system is now available in select European countries.
Mon Nov 24, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.